Personalized chemo for pancreatic cancer: a step closer?
NCT ID NCT04469556
First seen Feb 23, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This study looked at 150 people with advanced pancreatic cancer that had spread. It compared two standard chemotherapy treatments to see which works better and used lab tests to find markers that could predict the best treatment for each person. The goal was to improve how we choose treatments for this tough disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BC Cancer Agency Vancouver
Vancouver, British Columbia, V5Z 1L8, Canada
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Northwell Health
New Hyde Park, New York, 11042, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2N9, Canada
Conditions
Explore the condition pages connected to this study.